Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?

Transarterial chemoembolization (TACE) with drug-saturated microspheres is used in the treatment of women with pelvic tumors complicated by bleeding. Another serious problem is peritoneal carcinomatosis. However, it has not been studied whether TACE affects peritoneal lesions, is there a difference...

Full description

Bibliographic Details
Main Authors: E. A. Zvezdkina, A. G. Kedrova, D. P. Lebedev, T. A. Greyan, D. N. Panchenkov, Yu. A. Stepanova
Format: Article
Language:Russian
Published: ABV-press 2022-09-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/974
_version_ 1797876035917709312
author E. A. Zvezdkina
A. G. Kedrova
D. P. Lebedev
T. A. Greyan
D. N. Panchenkov
Yu. A. Stepanova
author_facet E. A. Zvezdkina
A. G. Kedrova
D. P. Lebedev
T. A. Greyan
D. N. Panchenkov
Yu. A. Stepanova
author_sort E. A. Zvezdkina
collection DOAJ
description Transarterial chemoembolization (TACE) with drug-saturated microspheres is used in the treatment of women with pelvic tumors complicated by bleeding. Another serious problem is peritoneal carcinomatosis. However, it has not been studied whether TACE affects peritoneal lesions, is there a difference in peritoneal lesions with primary and recurrent tumors? The purpose of this article is to analyze the results of TACE in women with peritoneal lesions with primary and recurrent pelvis tumors. This is an analysis of 80 patients with primary tumors (group 1) and 20 patients with recurrent tumors of pelvis (group 2). 8 women in group 1 and 11 women in group 2 had an implantation lesion of peritoneum near the main focus, 3 women in group 1 and 4 women in group 2 had a peritoneum lesion at a distance from the main focus. Angiography revealed differences in blood supply of implantation metastases in the group of primary and recurrent tumors, as well as the blood supply of distant peritoneal metastases. These facts should be taken into account in order to reduce the number of errors in assessing the effectiveness of therapy, to obtain a good clinical result, and to avoid discrediting TACE due to unreasonable requirements for it.
first_indexed 2024-04-10T01:55:53Z
format Article
id doaj.art-d7a5a19bfbbb499f83fc5be5e8fce617
institution Directory Open Access Journal
issn 1994-4098
1999-8627
language Russian
last_indexed 2024-04-10T01:55:53Z
publishDate 2022-09-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj.art-d7a5a19bfbbb499f83fc5be5e8fce6172023-03-13T08:44:38ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272022-09-01182869210.17650/1994-4098-2022-18-2-86-92740Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?E. A. Zvezdkina0A. G. Kedrova1D. P. Lebedev2T. A. Greyan3D. N. Panchenkov4Yu. A. Stepanova5ФГБУ «Государственный научный центр лазерной медицины им. О.К. Скобелкина Федерального медико-биологического агентства»ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства России»ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства»ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства»ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр хирургии им. А.В. Вишневского» Минздрава РоссииTransarterial chemoembolization (TACE) with drug-saturated microspheres is used in the treatment of women with pelvic tumors complicated by bleeding. Another serious problem is peritoneal carcinomatosis. However, it has not been studied whether TACE affects peritoneal lesions, is there a difference in peritoneal lesions with primary and recurrent tumors? The purpose of this article is to analyze the results of TACE in women with peritoneal lesions with primary and recurrent pelvis tumors. This is an analysis of 80 patients with primary tumors (group 1) and 20 patients with recurrent tumors of pelvis (group 2). 8 women in group 1 and 11 women in group 2 had an implantation lesion of peritoneum near the main focus, 3 women in group 1 and 4 women in group 2 had a peritoneum lesion at a distance from the main focus. Angiography revealed differences in blood supply of implantation metastases in the group of primary and recurrent tumors, as well as the blood supply of distant peritoneal metastases. These facts should be taken into account in order to reduce the number of errors in assessing the effectiveness of therapy, to obtain a good clinical result, and to avoid discrediting TACE due to unreasonable requirements for it.https://ojrs.abvpress.ru/ojrs/article/view/974артериальная химиоэмболизациярецидивная опухольрак шейки маткирак тела маткимагнитно-резонансная томографияhepasphereперитонеальный карциноматозангиографияафференты опухоли
spellingShingle E. A. Zvezdkina
A. G. Kedrova
D. P. Lebedev
T. A. Greyan
D. N. Panchenkov
Yu. A. Stepanova
Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
Опухоли женской репродуктивной системы
артериальная химиоэмболизация
рецидивная опухоль
рак шейки матки
рак тела матки
магнитно-резонансная томография
hepasphere
перитонеальный карциноматоз
ангиография
афференты опухоли
title Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_full Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_fullStr Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_full_unstemmed Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_short Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
title_sort transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement what results can be expected
topic артериальная химиоэмболизация
рецидивная опухоль
рак шейки матки
рак тела матки
магнитно-резонансная томография
hepasphere
перитонеальный карциноматоз
ангиография
афференты опухоли
url https://ojrs.abvpress.ru/ojrs/article/view/974
work_keys_str_mv AT eazvezdkina transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT agkedrova transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT dplebedev transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT tagreyan transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT dnpanchenkov transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected
AT yuastepanova transarterialchemoembolizationinthetreatmentofprimaryandrecurrentpelvictumorswithperitonealinvolvementwhatresultscanbeexpected